Breaking News
2 hours ago
Vaibhavi M.
Moderna settles Arbutus, Genevant patent litigation for $950M.
Vaibhavi M.
Teva secures $400M from Blackstone to advance Phase 3 TL1A mAb duvakitug.
Vaibhavi M.
GSK closes $2.2B RAPT deal, adds Phase IIb anti-IgE ozureprubart.
Vaibhavi M.
Acadia adds Vertex finance SVP Jonathan Poole to board, Audit Committee.
Vaibhavi M.